HOPON (Hyperbaric Oxygen for the Prevention of... (2018 study) Skip to main content
RCT Trials 2018

HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible: study protocol for a randomised controlled trial.

Shaw R, Butterworth C, Tesfaye B, Bickerstaff M, Dodd S, Smerdon G, et al., Trials, 2018

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors describe the plan for a large trial that will test whether hyperbaric oxygen helps prevent bone damage in the jaw when patients who have had radiotherapy need a high-risk dental procedure.

What They Found

This paper is a protocol for a phase III, multi-centre randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible, and it reports no patient results. Eligible patients need a high-risk dental procedure in the mandible and must have received at least 50-Gy radiotherapy. They are randomised 1:1 to a hyperbaric oxygen arm (Marx protocol) or a control arm, and both groups receive antibiotics and chlorhexidine mouthwash. The primary endpoint is osteoradionecrosis at 6 months after surgery. Secondary endpoints include other time points, acute symptoms and pain, quality of life, and implant retention where implants are placed. The authors state that the evidence for hyperbaric oxygen remains poor and that current practice varies greatly.

What This Means for Canadian Patients

This paper gives no results, so it cannot show whether hyperbaric oxygen prevents osteoradionecrosis after dental surgery in a previously irradiated jaw. The abstract says the evidence for its use is poor and practice varies. Patients facing a dental extraction or implant after head and neck radiotherapy should talk with their care team about their own options.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a protocol, the paper has no outcome data, and the trial is unblinded, although a blinded expert panel will assess the primary endpoint using anonymised photographs and radiographs.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Radiation Injury
Source Pubmed
PubMed ID 29316962
Year Published 2018
Journal Trials
MeSH Terms Clinical Trials, Phase III as Topic; Humans; Hyperbaric Oxygenation; Mandible; Multicenter Studies as Topic; Osteoradionecrosis; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Sample Size; Translational Research, Biomedical

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology